News Medical

Characterization of Liposome Size and Encapsulation using FFF-MALS-QELS

Liposomes are synthetic vesicles composed of a lipid bilayer surrounding an aqueous core in which drugs can be contained. These vesicles therefore provide a valuable mechanism for drug delivery in the ...
Nature

Targeted radiosensitisation by pegylated liposome-encapsulated 3′, 5′-O-dipalmitoyl 5-iodo-2′-deoxyuridine in a head and neck cancer xenograft model

5-Iodo-2′-deoxyuridine (IUdR) is an effective radiosensitiser but its clinical development has been limited by toxicity. Prolonged intravenous infusions of IUdR are necessary for optimal tumour uptake ...
ascopubs.org

Liposome-encapsulated doxorubicin plus paclitaxel and trastuzumab as neoadjuvant chemotherapy for operable and locally advanced breast cancer.

A single-dose, crossover, placebo- and moxifloxacin-controlled study to assess the effects of neratinib (HKI-272) on cardiac repolarization in healthy adult subjects. Background: Schedules with ...
ascopubs.org

Liposome-Encapsulated Doxorubicin in Combination With Standard Agents (cyclophosphamide, vincristine, prednisone) in Patients With Newly Diagnosed AIDS-Related Non-Hodgkin's ...

Fludarabine Plus Mitoxantrone With and Without Rituximab Versus CHOP With and Without Rituximab As Front-Line Treatment for Patients With Follicular Lymphoma To evaluate the safety and efficacy of ...
FierceBiotech

Insys Therapeutics Receives FDA Orphan Drug Designation for Its Liposomal Encapsulated Paclitaxel for the Treatment of Ovarian Cancer

PHOENIX, AZ, Jan 26, 2015 (Marketwired via COMTEX) -- Insys Therapeutics, Inc. INSY, +0.10% a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug ...
manilatimes

GenuinePurity Liposomal NMN: How Cell-Mimicking Absorption Technology at 250mg Addresses the NAD+ Bioavailability Question for Cellular Energy Support

Comprehensive Analysis Examines Liposomal NMN Delivery, Dosage Research Context, Third-Party Verification Standards, and What Distinguishes GenuinePurity's NAD+ Precursor Formulation in an Expanding ...
FiercePharma

Insys Therapeutics Receives FDA Orphan Drug Designation for Its Liposomal Encapsulated Paclitaxel for the Treatment of Ovarian Cancer

Insys Therapeutics, Inc. (NASDAQ: INSY), a specialty pharmaceutical company that is developing and commercializing innovative drugs and novel drug delivery systems, today announced that the U.S. Food ...